FUJIFILM Holdings Corporation

Corporate brand

Unclaimed Request correction

Japanese technology group whose businesses span healthcare, imaging, advanced materials and business innovation.

Last updated November 4, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

FUJIFILM Holdings Corporation is a Japanese technology holding company headquartered in Tokyo. Its origins lie in Fuji Photo Film Co., Ltd., established in 1934 under a national industrial initiative to create a domestic photographic-film manufacturer. The group initially built its capabilities around photographic film, photographic paper, dry plates and related photosensitive materials, later extending those technologies into cameras, optical products, motion-picture film, color processing and other imaging businesses. The company is best known internationally as Fujifilm, a name associated with photographic film, digital cameras, the X Series mirrorless system and the INSTAX instant-photo product family. However, the modern holding company is substantially broader than a consumer-imaging brand. Fujifilm’s business portfolio includes medical imaging and healthcare information systems, endoscopy and ultrasound-related equipment, biopharmaceutical development and manufacturing services, regenerative-medicine technologies, electronic materials for semiconductor production, graphic arts and commercial printing, office and document solutions, optical devices and industrial materials. A decisive turning point came as demand for conventional photographic film declined sharply from around 2000 onward. Rather than relying on film as its principal growth engine, Fujifilm used accumulated expertise in chemicals, coatings, precision engineering, optics, imaging and information management to create what it describes as a second foundation for the company. This transformation redirected investment toward healthcare, highly functional materials, business innovation and new forms of imaging, while retaining selected photographic businesses with strong customer and brand appeal. The group reorganized into a holding-company structure in 2006. FUJIFILM Holdings Corporation became the parent company, while the operating businesses were transferred primarily to FUJIFILM Corporation and Fuji Xerox. Fuji Xerox, later renamed FUJIFILM Business Innovation Corporation, broadened the group’s presence in office printing, production printing, workflow software and document services. The restructuring allowed the parent company to allocate capital and manage a portfolio of businesses rather than operate primarily as a photographic-film manufacturer. Healthcare has become one of Fujifilm’s central strategic growth areas. The group presents its healthcare activities as extending from prevention through diagnosis and treatment. Its portfolio combines diagnostic imaging, medical informatics, endoscopy, ultrasound, pharmaceuticals, contract development and manufacturing, cell technologies and other life-science capabilities. Acquisitions such as SonoSite, the former Hitachi diagnostic-imaging business and Cellular Dynamics International strengthened this expansion, while internal research continued to connect Fujifilm’s materials science and engineering capabilities with medical applications. Imaging remains important both commercially and symbolically. The X Series serves enthusiast and professional photographers with interchangeable-lens digital cameras and lenses, while INSTAX has developed into a global instant-photography platform focused on physical prints, social sharing and lifestyle use. Fujifilm has also continued selected photographic-film, motion-picture-film and archival-imaging activities, although these represent only part of the diversified group. The company’s corporate communications emphasize sustained innovation and the application of technology to social and industrial challenges. “Value from Innovation,” adopted as a corporate slogan in 2014, expressed this direction, while the “NEVER STOP” campaign launched in 2018 presented the transformation from film producer to diversified technology group. In 2021, Fujifilm expanded that branding platform and introduced separate communications for FUJIFILM Business Innovation. The group there…

History

FUJIFILM Holdings traces its history to Fuji Photo Film Co., Ltd., established in January 1934 as part of a Japanese effort to build domestic photographic-film production. Its first factory produced photographic film, print paper, dry plates and related photosensitive materials. During the following decades, the company expanded into color photography, optical products, cameras, motion-picture film, processing services and other imaging technologies. The business developed a distinctive technical base in chemistry, coatings, optics, precision manufacturing and image reproduction. The post-war period brought international expansion and a widening product portfolio. Fujifilm established overseas subsidiaries, developed consumer and professional photographic products, and participated in the creation of Fuji Xerox in 1962 with Rank Xerox. Fuji Xerox eventually became an important business in office equipment, copying, printing, document management and workflow solutions. Fujifilm also entered adjacent areas such as magnetic media, optical components and industrial materials, building capabilities that later supported diversification. The arrival of digital photography disrupted the traditional film industry. From approximately 2000, demand for photographic film fell substantially, creating a strategic challenge for Fujifilm and its competitors. Fujifilm responded by identifying technologies developed for film production that could be reused in other markets. These included thin-film coating, functional chemicals, imaging sensors and processing, high-precision production, materials design and quality-control systems. The resulting transformation shifted capital and research toward healthcare, highly functional materials, business innovation and new imaging businesses. In 2006, Fuji Photo Film reorganized as a holding company and adopted the name FUJIFILM Holdings Corporation. The former operating activities were transferred primarily to newly organized operating companies, including FUJIFILM Corporation, while Fuji Xerox became a wholly owned subsidiary within the group structure. The holding-company model separated portfolio management from day-to-day operations and made it easier to pursue acquisitions and coordinate businesses with different customers and investment cycles. Healthcare became a major pillar of the transformation. Fujifilm expanded from diagnostic imaging into healthcare information systems, endoscopy, ultrasound, pharmaceuticals, biopharmaceutical services and regenerative medicine. The acquisition of Toyama Chemical added pharmaceutical capabilities. SonoSite strengthened point-of-care ultrasound, the former Hitachi diagnostic-imaging business broadened medical-imaging capabilities, and Cellular Dynamics International provided a route into industrialized human-cell technologies and iPS-cell-related drug-discovery support. The group’s stated healthcare ambition has been to address prevention, diagnosis and treatment as a connected portfolio. Fujifilm also retained and renewed its imaging heritage. The X Series and GFX systems positioned the brand in premium digital photography, while INSTAX revived the appeal of physical instant prints for younger and lifestyle-oriented audiences. Marketing increasingly presented photography as a social and creative activity rather than only as a technical recording process. In parallel, the group expanded electronic materials, graphic arts, commercial printing and document solutions, applying its materials and imaging expertise to industrial and enterprise markets. Corporate branding reinforced the strategic shift. “Value from Innovation,” introduced in 2014, articulated the company’s emphasis on creating value through technology. In 2018, the “NEVER STOP” campaign communicated the group’s continuing reinvention and its broad portfolio. In 2021, Fujifilm introduced “NEVER STOP 2021” and a separate “Accelerate your business success” campaign for FUJIFILM Business Innovation. Through these changes, the company evolved from a photographic-film producer into a diversified technology group while preserving Fujifilm as a recognizable consumer and professional brand.

2023
Electronic Materials Process Chemicals expands
[9]Entegris electronic-chemicals acquisition completionfinance.yahoo.com
Fujifilm completed its acquisition of an Entegris electronic-chemicals business, adding sites and products for semiconductor manufacturing.
2021
FUJIFILM Business Innovation branding begins
[5]NEVER STOP 2021 and Accelerate your business successholdings.fujifilm.com
Fuji Xerox was rebranded as FUJIFILM Business Innovation, accompanied by a corporate campaign focused on helping business customers accelerate performance.
2018
NEVER STOP campaign launches
[4]NEVER STOP global branding campaignholdings.fujifilm.com
The group launched a global branding platform focused on continued innovation and its transition beyond photographic film.
2017
Hitachi diagnostic-imaging business acquired
[11]SonoSite acquisitiondcfmodeling.com
Fujifilm acquired Hitachi’s diagnostic-imaging business, broadening its healthcare-imaging operations.
2015
Cellular Dynamics transaction announced
[6]Cellular Dynamics International acquisition announcementprnewswire.com
Fujifilm announced the acquisition of Cellular Dynamics International to expand into iPS-cell technologies and regenerative-medicine support.
2012
SonoSite acquisition
[11]SonoSite acquisitiondcfmodeling.com
Fujifilm acquired SonoSite, strengthening its position in compact and point-of-care ultrasound.
2008
Toyama Chemical acquisition
[10]Toyama Chemical acquisitioncompanieshistory.com
Fujifilm acquired Toyama Chemical, adding pharmaceutical capabilities to its expanding healthcare portfolio.
2006
Holding-company reorganization
[3]Company Profileholdings.fujifilm.com
The former Fuji Photo Film organization became FUJIFILM Holdings Corporation, with operating businesses transferred to separate group companies.
1962
Fuji Xerox is established
[2]History of Fujifilm Groupholdings.fujifilm.com
Fuji Xerox was formed as a joint venture with Rank Xerox, creating the foundation for Fujifilm’s later office-printing and document-solutions business.
1934
Fuji Photo Film is established
[2]History of Fujifilm Groupholdings.fujifilm.com
Fuji Photo Film Co., Ltd. was established to develop domestic photographic-film manufacturing and began production of film, photographic paper, dry plates and related materials.

Products and positioning

A diversified Japanese technology group using expertise in imaging, chemistry, materials science, optics and precision engineering across healthcare, advanced materials, business innovation and consumer imaging.

Digital cameras and lenses · 2011
FUJIFILM X Series
The X Series is Fujifilm’s interchangeable-lens digital-camera system for enthusiasts and professionals. It combines compact camera bodies, Fujinon lenses, distinctive color science and film-simulation modes that reference the company’s photographic-film heritage. The line spans compact rangefinder-style and DSLR-style bodies, with supporting accessories and lenses for travel, documentary, portrait and commercial photography.
Medium-format digital imaging · 2016
FUJIFILM GFX System
The GFX System is Fujifilm’s premium large-sensor digital-imaging platform. It targets professional photographers, studios, commercial image-makers and demanding enthusiasts seeking high resolution and tonal detail. The system includes medium-format camera bodies, interchangeable lenses and workflow support, extending Fujifilm’s imaging expertise into a higher-performance segment.
Instant photography · 1998
INSTAX
INSTAX is Fujifilm’s instant-photography family, including instant cameras, instant film and smartphone-connected or digital-hybrid printers. Its proposition centers on producing physical photographs quickly and sharing them as gifts, keepsakes and social mementos. The brand connects Fujifilm’s imaging heritage with lifestyle, entertainment, travel and creator-oriented use cases.
Medical technology and healthcare IT
FUJIFILM healthcare solutions
Fujifilm’s healthcare portfolio includes diagnostic-imaging systems, medical information systems, endoscopy, ultrasound and related clinical workflow technologies. These offerings apply the group’s expertise in imaging, optics, electronics, software and materials to hospitals, clinics and other healthcare providers. The portfolio is supported by broader pharmaceutical, biopharmaceutical and life-science activities.
Biopharmaceutical development and manufacturing
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies provides contract development and manufacturing services for biopharmaceutical products. Its activities support development, process manufacturing and production infrastructure for biologics, vaccines and other advanced therapies. The business is part of Fujifilm’s strategy to extend healthcare from diagnosis into treatment and life-science manufacturing.
Printing and document solutions · 2021
FUJIFILM Business Innovation
FUJIFILM Business Innovation develops office multifunction devices, production-printing systems, workflow software, document-management tools and related services. Formerly associated with Fuji Xerox, the business serves enterprise, commercial-printing and office customers. Its portfolio combines hardware, software, automation and service support for managing physical and digital documents.
Semiconductor materials
FUJIFILM Electronic Materials
Fujifilm supplies electronic materials and process chemicals used in semiconductor manufacturing and other advanced electronics applications. The portfolio was expanded through acquisitions, including the electronic-chemicals business purchased from Entegris in 2023. Manufacturing sites positioned near semiconductor-production centers support supply continuity and customer collaboration.

Marketing campaigns

2023Join the Fujifilm Family
Canada
FUJIFILM Canada promoted the X Series through a series of humorous vignettes that personified product features such as film simulations and connected them with different types of photographers and creators.
Outcome. The campaign used character-driven storytelling to explain differentiated camera features and build affinity with creators.
Source
2021NEVER STOP 2021
Global
The follow-up campaign presented Fujifilm products, technologies and services as contributors to solutions for social challenges, with examples from healthcare, document solutions and other group businesses.
Outcome. It refreshed the corporate narrative around innovation and societal contribution.
Source
2019Don’t just take, give
Global
Fujifilm and McCann introduced a global INSTAX branding campaign centered on the idea that instant photographs can be printed and given to other people. Advertising portrayed photography as a way to create shared memories across friendships, travel and everyday experiences.
Outcome. The campaign broadened INSTAX communication from product awareness toward emotional sharing and social connection.
Source
2018NEVER STOP
Japan · United States · Europe · China · Southeast Asia
Fujifilm launched a global corporate-branding campaign to communicate the breadth of its businesses and its determination to continue developing new value from its technologies and expertise. The campaign explicitly linked the company’s diversification to the decline of traditional photographic film.
Outcome. The campaign established a group-wide expression of Fujifilm’s transformation and innovation agenda.
Source
Make More
United States
FUJIFILM Business Innovation used the “Make More” platform to promote printing products, software, automation and support services as tools for commercial printers seeking efficiency and growth.
Source

Brand decisions

2023
Acquire Entegris electronic-chemicals businessM&A
Background
Fujifilm aimed to expand its semiconductor-materials portfolio and manufacturing presence near major chip-production centers.
Action taken
The company completed the acquisition of Entegris’s electronic-chemicals business and renamed it FUJIFILM Electronic Materials Process Chemicals.
Aftermath
The transaction added products, employees and manufacturing locations to Fujifilm’s electronic-materials operations.
Announced purchase price. US$700 million (2023 acquisition)
Source
2021
Rebrand Fuji Xerox as FUJIFILM Business InnovationStrategy
Background
The group sought a unified identity for its document and printing business after changes in its relationship with Xerox.
Action taken
Fuji Xerox was renamed FUJIFILM Business Innovation and promoted through a dedicated “Accelerate your business success” campaign.
Aftermath
The renamed business became more directly integrated into Fujifilm’s corporate brand architecture while continuing to serve document and printing markets.
Source
2018
Launch the NEVER STOP corporate brand platformStrategy
Background
Fujifilm needed to explain its transformation from a film-centered company to a diversified technology group.
Action taken
The company introduced NEVER STOP as a global campaign highlighting innovation, business diversity and continued growth.
Aftermath
The platform became a recurring expression of Fujifilm’s reinvention and technology-led positioning.
Source
2015
Acquire Cellular Dynamics InternationalM&A
Background
Fujifilm sought to expand healthcare beyond diagnostic products into regenerative medicine and iPS-cell-based drug-discovery support.
Action taken
The company agreed to acquire Cellular Dynamics International through an all-cash tender offer followed by a merger.
Aftermath
Cellular Dynamics became a consolidated Fujifilm subsidiary and added human-cell development and manufacturing capabilities to the group’s life-science portfolio.
Announced transaction value. Approximately US$307 million on a fully diluted basis (2015 announcement)
Source
2006
Create a holding-company structureStrategy
Background
The company was restructuring as the traditional photographic-film business faced long-term technological disruption and the group needed to manage a more diversified portfolio.
Action taken
Fuji Photo Film reorganized as FUJIFILM Holdings Corporation and transferred operating businesses to separate subsidiaries, including FUJIFILM Corporation and Fuji Xerox.
Aftermath
The structure supported portfolio diversification and positioned Fujifilm to allocate resources across healthcare, materials, imaging and document solutions.
Source

Sources12 sources

Cite this profile: Cite the canonical profile. /brand-wiki/fujifilm-holdings-corporation · Editorial policy · How profiles are compiled